Wearable Device
MC-Rx Formalizes Pharmacy Benefit Coverage for Theranica’s Nerivio®, Providing Millions of Covered Members Access to the Novel Drug-Free Migraine Therapeutic
Nerivio, a drug-free Remote Electrical Neuromodulation (REN) device for the acute treatment of migraine in patients 12 years and older.
Nerivio Acute Migraine Therapeutic Device Is Now Available to Veterans
Nerivio has shown clinical efficacy for episodic and chronic migraine, both in clinical trials and real-world evidence analyses reports Jason Sico, MD, Associate Professor of Neurology and Internal Medicine in Yale School of Medicine.
Remote Electrical Neuromodulation Reported As Viable Alternative to Drugs for Acute Migraine
Remote Electrical Neuromodulation: "This study signals a potentially significant shift in how we approach the acute treatment of migraine," said lead author Michael Marmura, MD, Headache Specialist at the Thomas Jefferson University Hospital in Philadelphia.
